| ²é¿´: 457 | »Ø¸´: 1 | |||
gouyugouyuгæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖúÕâ¸öÔÁÏÒ©µÄĬ¿ËË÷Òý ÒÑÓÐ1È˲ÎÓë
|
|
Çó´óÉñ£¬ÇóÖúÕâ¸öÔÁÏÒ©µÄĬ¿ËË÷Òý CAS: 129938-20-1 |
» ²ÂÄãϲ»¶
ʹÓÃMolAICal½øÐжàëÄÐéÄâɸѡ½Ì³Ì-ͬÑùÊÊÓÃÓÚµ°°×ÖʺͺËËáµÄÐéÄâɸѡ
ÒѾÓÐ1È˻ظ´
ʹÓÃMolAICal¼ÆËãÒ©Îﻯѧ¹ýÂËÆ÷MCFs¼°MCE-18ÃèÊö·û
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ74È˻ظ´
ʹÓÃMolAICal·¢ÏÖµ°°×ÊÜÌåDZÔڵĻîÐÔ¿Ú´ü¼°Î»µã
ÒѾÓÐ0È˻ظ´
288·ÖÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
»ªÀíҩѧѧ˶Çóµ÷¼Á£¬×Ü·Ö324
ÒѾÓÐ0È˻ظ´
½Î÷¿Æ¼¼Ê¦·¶´óѧ΢ÉúÎïÌìȻҩÎïÀÏʦ½éÉÜ
ÒѾÓÐ23È˻ظ´
Ò»Ö¾Ô¸ËÕÖÝ´óѧ ÉúÎï¼¼ÊõÓ빤³Ì£¨086001£© ³õÊÔ323·Ö£¬Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
°ÄÃÅÀí¹¤´óѧÈ˹¤ÖÇÄÜÒ©Îï·¢ÏÖÖÐÐÄÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú£¨ÉêÇë-¿¼ºËÖÆ£©
ÒѾÓÐ10È˻ظ´
ÈýÄêʵÑéÊÒ¹¤×÷¾Àú£¬Ò»Ö¾Ô¸»ªÖÐũҵ´óѧ΢ÉúÎ×Ü·Ö288Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
070700Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
k8zj
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÁªºÏ¹ú´óʹ
- DRDEPI: 1
- Ó¦Öú: 21 (СѧÉú)
- ¹ó±ö: 18.748
- ½ð±Ò: 227486
- É¢½ð: 8093
- ºì»¨: 486
- ɳ·¢: 45
- Ìû×Ó: 19705
- ÔÚÏß: 5212.4Сʱ
- ³æºÅ: 617003
- ×¢²á: 2008-10-04
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
- ¹ÜϽ: ±ê×¼ÓëרÀû
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
gouyugouyu: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú 2016-01-19 12:56:41
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
gouyugouyu: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú 2016-01-19 12:56:41
|
2821. Dapoxetine Nomenclature CAS number: 119356-77-3 (¦ÁS)-N,N-Dimethyl-¦Á-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine; (+)-N,N-dimethyl-1-phenyl-3-(1-naphthalenyloxy)propanamine; LY-210448. C21H23NO; mol wt 305.41. C 82.59%, H 7.59%, N 4.59%, O 5.24%. Description and references Selective serotonin reuptake inhibitor (SSRI). Prepn: D. W. Robertson et al., EP 288188; eidem, US 5135947 (1988, 1992 both to Lilly). Synthesis: W. J. Wheeler, D. D. O'Bannon, J. Labelled Compd. Radiopharm. 31, 305 (1992) DOI; S. Kang, H.-K. Lee, J. Org. Chem. 75, 237 (2010) DOI PubMed. HPLC determn in plasma: C. L. Hamilton, J. D. Cornpropst, J. Chromatogr. 612, 253 (1993) DOI PubMed. Clinical pharmacokinetics: N. B. Modi et al., J. Clin. Pharmacol. 46, 301 (2006) DOI PubMed. Clinical trial: J. L. Pryor et al., Lancet 368, 929 (2006) DOI PubMed; C. G. McMahon et al., J. Sex. Med. 8, 524 (2011) DOI PubMed. Review of pharmacology and clinical experience: B. Feret, Formulary 40, 227-230 (2005); A. M. Feige et al., Clin. Pharmacol. Ther. 89, 125 (2011) DOI PubMed. Chemical structure Properties Colorless oil. [¦Á]D28 + 63.2¡ã (c=0.3 in chloroform). Derivative Hydrochloride. Nomenclature CAS number: 129938-20-1 Priligy (Janssen-Cilag). C21H23NO.HCl; mol wt 341.87. C 73.78%, H 7.08%, N 4.10%, O 4.68%, Cl 10.37%. Properties White crystalline solid from hydrochloric acid and ethyl acetate. [¦Á]D +135.78¡ã (c = 2.18 in methanol). Therapeutic Category In treatment of premature ejaculation. Keywords Serotonin Uptake Inhibitor |

2Â¥2016-01-15 10:29:59














»Ø¸´´ËÂ¥